Adherence
Positive Airway Pressure (PAP) therapy, while effective for reducing AHI and improving symptoms, has not demonstrated a benefit on composite cardiovascular endpoints in randomized controlled trials.
PAP is the standard treatment for OSA and effectively reduces breathing interruptions and daytime sleepiness. However, it does not appear to reduce long-term cardiovascular risks like heart attacks or strokes in large studies, and many patients struggle with adherence due to discomfort. It remains a good option for symptomatic relief and blood pressure control, but may not be a 'one-size-fits-all' solution.
PAP has not demonstrated a benefit on composite cardiovascular endpoints in randomized controlled trials for primary [23] or secondary cardiovascular prevention [24–26]. For example, in the largest randomized trial to date (Sleep Apnea Cardiovascular Endpoints, SAVE), there was no difference in the incidence of strokes, heart attacks, composite cardiovascular mortality, or other cardiovascular endpoints between the PAP and usual‑care groups [24].
Why this rating
Based on large RCTs like SAVE and meta-analyses.
Source
Obstructive Sleep Apnea: An Evolving Therapeutic Landscape with an Emerging Role for Incretin-Based Therapies
Bugao Xu et al. · Advances in Therapy · 2025
DOI 10.1007/s12325-025-03312-6
More from this paper
- Tirzepatide, a dual GLP-1 and GIP agonist, significantly reduces Obstructive Sleep Apnea (OSA) severity and body weight in patients with moderate-to-severe OSA and obesity, marking the first FDA-approved pharmacotherapy for this condition.Good
- Weight loss, achieved through lifestyle changes, medications, or bariatric surgery, is associated with significant improvements in OSA severity, with a 20% BMI reduction leading to an average 57% decrease in AHI.Good
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →